Development and pharmacokinetic evaluation of osmotically controlled drug delivery system of Valganciclovir HCl for potential application in the treatment of CMV retinitis-Reference-Cited by-同舟云学术

Development and pharmacokinetic evaluation of osmotically controlled drug delivery system of Valganciclovir HCl for potential application in the treatment of CMV retinitis

Published:2022-03-07 Issue:11 Volume:12 Page:2708-2729
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Gundu Ramakanth^ORCID,Pekamwar Sanjay,Shelke Santosh^ORCID,Kulkarni Deepak^ORCID,Gadade Dipak,Shep Santosh

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

https://link.springer.com/content/pdf/10.1007/s13346-022-01122-9.pdf

Reference51 articles.

1. Tan BH. Cytomegalovirus treatment. Curr Treat Options Infect Dis. 2014;6(3):256–70. https://doi.org/10.1007/s40506-014-0021-5.

2. Tseng A, Foisy M. The role of ganciclovir for the management of cytomegalovirus retinitis in HIV patients: pharmacological review and update on new developments. Can J Infect Dis. 1996;7(3):183–94. https://doi.org/10.1155/1996/780831.

3. Cvetković RS, Wellington K. Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients. Drugs. 2005;65(6):859–78. https://doi.org/10.2165/00003495-200565060-00012.

4. Vaziri S, Pezhman Z, Sayyad B, Mansouri F, Janbakhsh A, Afsharian M, N. F. Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: ameta-analysis. J Res Med Sci. 2014;19(12):1185–92.

5. Ahmed JA. A review on immediate release tablet dosage form. Int J Pharm Pharm Res. 2015;2(23):1–17.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osmotic Pump Drug Delivery Systems—A Comprehensive Review;Pharmaceuticals;2022-11-18